๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A phase II trial to evaluate the efficacy of bexarotene gel 1% in patients with parapsoriasis (T0 cutaneous T-cell lymphoma)

Book ID
116580271
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
44 KB
Volume
52
Category
Article
ISSN
1097-6787

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

RESEARCH REPORT Bexarotene capsules and
RESEARCH REPORT Bexarotene capsules and gel for previously treated patients with cutaneous T-cell lymphoma: Results of the Australian patients treated on phase II trials
โœ H Miles Prince; Christopher McCormack; Gail Ryan; Christopher Baker; Harvey Rots ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 54 KB

## SUMMARY Bexarotene (Targretin^ยฎ^, LGD1069) is a novel synthetic retinoid analogue that binds selectively to retinoid X receptors. We describe eight previously treated patients who entered phase II international multicentre studies examining the role of bexarotene in cutaneous Tโ€cell lymphoma. Pa

Results of a Phase II trial of oral bexa
Results of a Phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma
โœ David J. Straus; Madeleine Duvic; Timothy Kuzel; Steven Horwitz; Marie-France De ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 73 KB

## Abstract ## BACKGROUND. Bexarotene is one of the most active single agents for the treatment of recurring or refractory cutaneous Tโ€cell lymphoma (CTCL). Interferon alfa has also been used for many years as an effective treatment for this disease. The results in recent case reports of the combi

Phase II trial of interferon-ฮฑ-2a plus p
Phase II trial of interferon-ฮฑ-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma
โœ Vanna Chiarion-Sileni; Antonio Bononi; Cleto Veller Fornasa; Mariella Soraru; Ma ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 85 KB

## Purpose: To evaluate the efficacy and side effects of psolaren with ultraviolet light a (puva) and interferon-alpha-2a (ifn-alpha-2a) in patients with mycosis fungoides (mf) and sรฉzary syndrome (ss). ## Patients and methods: From may 1993 to january 1999, 63 symptomatic patients with all stage